Healthcare Tech

Before the pandemic, most people had never heard of Illumina, the California-based sequencing behemoth whose machines generate upwards of 90% of the world’s DNA data. And while Illumina might still not be a household name, over the last 15 months the technology it sells has become standard dinner table fare. Genetic vaccines, coronavirus variants, wastewater

For the myriad applications of artificial intelligence, Eric Schmidt, the onetime Google CEO, sees one area where it’s poised to unleash the most sweeping changes. “When I try to market the importance of AI, I say that AI will have its biggest impact in biology and health, because biology is so complicated,” Schmidt said Tuesday

In a wide-ranging and forthcoming interview, Eric Schmidt, the former Google CEO who helped steer the tech giant’s foray into health care, opened up about a host of issues facing the future of medicine. Among the topics Schmidt touched on in a half-hour conversation at the STAT Health Tech Summit: his upcoming role as the

Health tech startup Cityblock Health, with its mission of delivering stepped-up primary care to Medicaid patients, is finding its footing in the very cracks that the Covid-19 pandemic has exposed. It’s leveraging its signature technology to help this highly marginalized population. “It’s very telling here that up until before the pandemic, there was a real

Investors are pouring into the health tech sector, with venture funding roughly doubling in 2020. That’s good for individual companies, but when valuations begin to depart from reality, it takes discerning investors to pick winners in the space. “It wasn’t always such a clear return profile, and there was a lot of skepticism,” Deena Shakir,

Mia Schloegel was 11 when they found the curve in her spine. She was at her yearly pediatrician’s visit when her uncle — also her doctor — had her lean over, in a standard childhood check for scoliosis. “He noticed I had kind of a hump on one side and not the other,” said Schloegel,

Kylene Redmond and Deb Foerster both are converts to their continuous glucose monitors, quarter-size devices that measure their blood sugar in real time so they can adjust their diet, their activity, and the medications they take to manage their diabetes. The automated sensors give both women feedback they can use to better control their disease

Amazon’s objectives for its nascent pharmacy business are straightforward: “better selection, better convenience, and better prices,” according to TJ Parker, the vice president of pharmacy at the company. “It really is the Amazon playbook,” he said during a Wednesday panel at STAT’s Health Tech Summit. Unlock this article by subscribing to STAT+ and enjoy your

WASHINGTON — Telehealth companies, flush with cash after the Covid-19 pandemic spiked both demand and investment, are now embarking on massive lobbying efforts to secure their interests on Capitol Hill. The goal is clear: Lawmakers are weighing whether to permanently loosen regulations that were temporarily eased during the pandemic. Among other changes, providers have been

For all the progress on Covid-19, we are still far from a post-pandemic world. “If you’re living on Planet Earth, I assure you the pandemic is not over,” Geeta Nayyar, executive medical director of Salesforce, said at the 2021 STAT Health Tech summit on Tuesday. “India and Brazil are great examples of the forest still

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

Kristen Campbell often felt like she was treating patients without all the pieces of the puzzle in front of her. As a clinical dietician at a large medical center, she usually had 15 minutes to run through their medical history  and squeeze in a new diet and exercise plan. It was only after taking a

Amazon Care signed its first enterprise customer this week, a significant milestone as the virtual-first health care platform looks to expand its footprint. The client, Precor, is a fitness business that was recently acquired by fitness technology company Peloton for $420 million in cash. Although small financially, the deal is a significant opener for Care,

Dyno Therapeutics, a Cambridge biotech that uses artificial intelligence techniques to develop gene therapies, said Thursday that it has raised $100 million from investors. The company uses machine learning to design a type of gene therapy “vector,” or carrier, aiming to make treatments that are easier to deliver and more effective. Dyno said the funding would

As an ICU physician, Leo Anthony Celi knows the immense power health data can hold. If it’s harnessed thoughtfully, it could speed diagnoses and drive better care. And if it isn’t wielded carefully, it can make matters worse. That’s why he’s become a prominent advocate for open data sharing as a way to make medical

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

A $1 million government contest to predict health problems with artificial intelligence attracted the heavyweights of industry and beyond — from Mayo Clinic, to IBM, to the data and consulting powerhouse Deloitte. But the winner of Medicare’s AI health outcomes challenge is a lesser-known startup from Austin, Texas, called ClosedLoop.ai. The company, whose victory was

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

Somewhere in Peter Maercklein’s heartbeat was an abnormality no one could find. He survived a stroke 15 years ago, but doctors never saw anything alarming on follow-up electrocardiograms. Then, one day last fall, an artificial intelligence algorithm read his EKGs and spotted something else: a ripple in the calm that indicated an elevated risk of

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science